OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
28
Results
Show all
Save search
Copy query
Show results for
Unknown
(28)
Publication Date
Release Date
2021
(9)
2025
(5)
2024
(4)
2023
(3)
2022
(2)
2017
(2)
2018
(1)
2015
(1)
2026
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Decline in Clinical Efficacy of Oral Miltefosine in Treatment of Post Kala-azar Dermal Leishmaniasis (PKDL) in India.
Not available
S-EPMC4619646
|
biostudies-literature
Cite
Antimony susceptible
Leishmania donovani
: evidence from
in vitro
drug susceptibility of parasites isolated from patients of post-kala-azar dermal leishmaniasis in pre- and post-miltefosine era.
Not available
S-EPMC11237457
|
biostudies-literature
Cite
Development of a rapid loop-mediated isothermal amplification assay for diagnosis and assessment of cure of Leishmania infection.
Not available
S-EPMC5363003
|
biostudies-literature
Cite
Robustic and hybrid cobalt doped BaFe<sub>12</sub>O<sub>19</sub> hexaferrites for the photocatalytic degradation of Congo Red for wastewater treatment.
Not available
S-EPMC11680785
|
biostudies-literature
Cite
Ribosomal protein control of hematopoietic stem cell transformation through regulation of metabolism.
Not available
S-EPMC12820725
|
biostudies-literature
Cite
DHARANI: A 3D Developing Human-Brain Atlas Resource to Advance Neuroscience Internationally Integrated Multimodal Imaging and High-Resolution Histology of the Second Trimester.
Not available
S-EPMC11794986
|
biostudies-literature
Cite
Preliminary model assessing the cost-effectiveness of preoperative chlorhexidine mouthwash at reducing postoperative pneumonia among abdominal surgery patients in South Africa.
Not available
S-EPMC8360544
|
biostudies-literature
Cite
TMPRSS2-ERG confers resistance to antiandrogens: mechanism and therapeutic implications
Not available
S-SCDT-10_1038-S44321-026-00423-7
|
biostudies-other
Cite
Pharmacokinetics, Efficacy, and Safety of a SARS-CoV-2 Antibody Treatment in Pediatric Participants: An Open-Label Addendum of a Placebo-Controlled, Randomized Phase 2/3 Trial.
Not available
S-EPMC10390421
|
biostudies-literature
Cite
The burden of cancers and their variations across the states of India: the Global Burden of Disease Study 1990-2016.
Not available
S-EPMC6167407
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets